Speaking as a person in the field - while true in general, in this particular case he is completely correct. Atypical antipsychotics have turned out to be massively misrepresented by the pharmaceutical companies. To avoid misunderstandings: I am a great supporter of pharmacological interventions, and I don't think that "Big Pharma" is an evil force, but this case has been one of the darkest spots on the image of the profession in the last decade.

The excellent and highly recommended "Mind Hacks" blog has been following the slow crash of the atypicals for a while. Latest can be seen here.